APA ציטוט

Tzeng, C. D., Balachandran, A., Ahmad, M., Lee, J. E., Krishnan, S., Wang, H., . . . Katz, M. H. G. (2014). Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. Blackwell Publishing Ltd.

Citação norma Chicago

Tzeng, Ching-Wei D., et al. Serum Carbohydrate Antigen 19-9 Represents a Marker of Response to Neoadjuvant Therapy in Patients With Borderline Resectable Pancreatic Cancer. Blackwell Publishing Ltd, 2014.

ציטוט MLA

Tzeng, Ching-Wei D., et al. Serum Carbohydrate Antigen 19-9 Represents a Marker of Response to Neoadjuvant Therapy in Patients With Borderline Resectable Pancreatic Cancer. Blackwell Publishing Ltd, 2014.